Therapeutic Strategies for Diastolic Dysfunction: A Clinical Perspective

키워드

참고문헌 (91)

1. Mitsunami K, "Three-month effects of can-desartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension", Cardiovasc Drugs Ther, 12, pp.469~474 (1998)
2. Angomachalelis N, "Improvement of left ventricular diastolic dysfunction in hypertensive patients 1 month after ACE inhibition therapy: evaluation by ultrasonic automated boundary detection", Heart Vessels, 11, pp.303~309 (1996)
3. Brilla CG, "Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease", Circulation, 102, pp.1388~1393 (2000)
4. López B, "Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients", Circulation, 104, pp.286~291 (2001)
5. Díez J, "Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients", Circulation, 105, pp.2512~2517 (2002)
6. Dahlöf B, "LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol", Lancet, 359, pp.995~1003 (2002)
7. Kahan T, "The importance of left ventricular hypertrophy in human hypertension", J Hypertens Suppl, 16, pp.s23~s29 (1998)
8. Warner JG Jr, "Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise", J Am Coll Cardiol, 33, pp.1567~1572 (1999)
9. Yusuf S, "CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARMPreserved Trial", Lancet, 362, pp.777~781 (2003)
10. Massie BM, "I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction", N Engl J Med, 359, pp.2456~2467 (2008)
11. Dumesnil JG, "Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension", Am J Cardiol, 68, pp.515~519 (1991)
12. Cheng CP, "Mechanism of augmented rate of left ventricular filling during exercise", Circ Res, 70, pp.9~19 (1992)
13. Gottdiener JS, "Clinical trials of single-drug therapy for the cardiac effects of hypertension", Am J Hypertens, 12, pp.s12~s18 (1999)
14. Kass DA, "Diastolic compliance of hypertrophied ventricle is not acutely altered by pharmacologic agents influencing active processes", Ann Intern Med, 119, pp.466~473 (1993)
15. Nishimura RA, "Failure of calcium channel blockers to improve ventricular relaxation in humans", J Am Coll Cardiol, 21, pp.182~188 (1993)
16. Setaro JF, "Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance", Am J Cardiol, 66, pp.981~986 (1990)
17. Betocchi S, "Effects of calcium antagonists on left ventricular structure and function", J Hypertens Suppl, 11, pp.s33~s37 (1993)
18. Iliceto S, "Left ventricular dysfunction: which role for calcium antagonists?", Eur Heart J, 18, pp.a87~a91 (1997)
19. Ramirez Gil JF, "In vivo left ventricular function and collagen expression in aldosterone", salt-induced hypertension, 1998, pp.32, 927~934
20. Pitt B, "The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators", N Engl J Med, 341, pp.709~717 (1999)
21. Silvestre JS, "Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis", Circulation, 99, pp.2694~2701 (1999)
22. Degre S, "Effects of spironolactone-altizide on left ventricular hypertrophy", Acta Cardiol, 53, pp.261~267 (1998)
23. Paulus WJ, "Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion", Circulation, 89, pp.2070~2078 (1994)
24. Kojda G, "Regulation of basal myocardial function by NO", Cardiovasc Res, 41, pp.514~523 (1999)
25. Matter CM, "Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy", Circulation, 99, pp.2396~2401 (1999)
26. "The effect of digoxin on mortality and morbidity in patients with heart failure", N Engl J Med, 336, pp.525~533 (1997)
27. Yanagisawa M, "A novel potent vasoconstrictor peptide produced by vascular endothelial cells", Nature, 332, pp.411~415 (1988)
28. Hirata Y, "Endothelin is a potent mitogen for rat vascular smooth muscle cells", Atherosclerosis, 78, pp.225~228 (1989)
29. Krum H, "Role of endothelin in the exercise intolerance of chronic heart failure", Am J Cardiol, 75, pp.1282~1283 (1995)
30. Cheng CP, "The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure", Am J Physiol Heart Circ Psysiol, 280, pp.h1853~h1860 (2001)
31. Shah AM, "8-bromocGMP reduces the myofilament response to Ca2+ in intact cardiac myocyte", Circ Res, 74, pp.970~978 (1994)
32. Yamamoto K, "Effect of the endogenous natriuretic peptide system on ventricular and coronary function in failing heart", Am J Physiol, 273, pp.h2406~h2414 (1997)
33. Clarkson PB, "Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure", Circulation, 93, pp.2037~2042 (1996)
34. Oi S, "Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells", Eur J Pharmacol, 376, pp.139~148 (1999)
35. Luo JD, "Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis", Clin Exp Pharmacol Physiol, 26, pp.903~908 (1999)
36. Hernández-Perera O, "Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells", Circ Res, 87, pp.616~622 (2000)
37. Park HJ, "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase", Proc Natl Acad Sci U S A, 96, pp.11525~11530 (1999)
38. Guijarro C, "3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture", Circ Res, 83, pp.490~500 (1998)
39. Patel R, "Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy", Circulation, 104, pp.317~324 (2001)
40. Sugden PH, "Stress-responsive” mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium", Circ Res, 83, pp.345~352 (1998)
41. Spurgeon HA, "Chronic exercise prevents characteristic age-related changes in rat cardiac contraction", Am J Physiol, 244, pp.h513~h518 (1983)
42. Starnes JW, "Myocardial adaptations to endurance exercise in aged rats", Am J Physiol, 245, pp.h560~h566 (1983)
43. Gwathmey JK, "The effect of exercise conditioning on excitation-contraction coupling in aged rat", J Appl Physiol, 69, pp.1366~1371 (1990)
44. Tate CA, "Enhanced calcium uptake of cardiac sarcoplasmic reticulum in exercise-trained old rats", Am J Physiol, 258, pp.h431~h435 (1990)
45. Colan SD, "Left ventricular diastolic function in elite athletes with physiologic cardiac hypertrophy", J Am Coll Cardiol, 6, pp.545~549 (1985)
46. Douglas PA, "Left ventricular structure and function by echocardiography in ultraendurance athletes", Am J Cardiol, 58, pp.805~809 (1986)
47. Nixon JV, "Effects of exercise on left ventricular diastolic performance in trained athletes", Am J Cardiol, 68, pp.945~949 (1991)
48. Matsuda M, "Effect of exercise on left ventricular diastolic filling in athletes and nonathletes", J Appl Physiol, 55, pp.323~328 (1983)
49. Forman DE, "Enhanced left ventricular diastolic filling associated with long-term endurance training", J Gerontol, 47, pp.m56~m58 (1992)
50. Takemoto KA, "Abnormalities of diastolic filling of the left ventricle associated with aging are less pronounced in exercise trained individuals", Am Heart J, 124, pp.143~148 (1992)
51. Douglas PS, "Aging and physical activity determine cardiac structure and function in the older athlete", J Appl Physiol, 72, pp.1969~1973 (1992)
52. Devereux RB, "Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study", J Hypertens, 20, pp.1445~1450 (2002)
53. Gandhi SK, "The pathogenesis of acute pulmonary edema associated with hypertension", N Engl J Med, 344, pp.17~22 (2001)
54. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, , Arch Intern Me, 2413~2446 (1997)
55. Joffres MR, "Awareness, treatment, and control of hypertension in Canada", Am J Hypertens, 10, pp.1097~1102 (1997)
56. Colhoun HM, "Blood pressure screening, management and control in England: results from the health survey for England 1994", J Hypertens, 16, pp.747~752 (1998)
57. Liu CP, "Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy. Systolic versus diastolic determinants", Circulation, 88, pp.1893~1906 (1993)
58. Mulieri LA, "Altered myocardial force-frequency relation in human heart failure", Circulation, 85, pp.1743~1750 (1992)
59. Gwathmey JK, "Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole", J Clin Invest, 87, pp.1023~1031 (1991)
60. Levine HJ, "Optimum heart rate of large failing hearts", Am J Cardiol, 61, pp.633~636 (1988)
61. Xiao HB, "Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy", Br Heart J, 68, pp.403~407 (1992)
62. Littmann L, "Hemodynamic implications of left bundle branch block", J Electrocardiol, 33, pp.115~121 (2000)
63. Saxon LA, "Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation", contraction sequence in patients with depressed ventricular function, 1998, pp.9, 13~21
64. Kerwin WF, "Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony", J Am Coll Cardiol, 35, pp.1221~1227 (2000)
65. Nishimura RA, "Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study", J Am Coll Cardiol, 25, pp.281~288 (1995)
66. Panidis IP, "Diastolic mitral regurgitation in patients with atrioventricular conduction abnormalities: a common finding by Doppler echocardiography", J Am Coll Cardiol, 7, pp.768~774 (1986)
67. Abraham WT, "Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure", N Engl J Med, 346, pp.1845~1853 (2002)
68. Wigle ED, "Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review", Prog Cardiovasc Dis, 28, pp.1~83 (1985)
69. Betocchi S, "Regional left ventricular mechanics in hypertrophic cardiomyopathy", Circulation, 88, pp.2206~2214 (1993)
70. Bonow RO, "Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil", J Am Coll Cardiol, 9, pp.1108~1116 (1987)
71. Severino S, "Use of pulsed Doppler tissue imaging to assess regional left ventricular diastolic dysfunction in hypertrophic cardiomyopathy", Am J Cardiol, 82, pp.1394~1398 (1998)
72. Sigwart U, "Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy", Lancet, 346, pp.211~214 (1995)
73. Knight C, "Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients", Circulation, 95, pp.2075~2081 (1997)
74. Lakkis NM, "Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy", Circulation, 98, pp.1750~1755 (1998)
75. McCully RB, "Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy", Circulation, 94, pp.467~471 (1996)
76. Seggewiss H, "Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients", J Am Coll Cardiol, 31, pp.252~258 (1998)
77. Weisfeldt ML, "Function of cardiac muscle in aging rat", Adv Exp Med Biol, 61, pp.95~118 (1975)
78. Weisfeldt ML, "Aging of the cardiovascular system", N Engl J Med, 303, pp.1172~1174 (1980)
79. Weisfeldt M, "Aging, changes in the cardiovascular system, and responses to stress", Am J Hypertens, 11, pp.s41~s45 (1998)
80. Lakatta EG, "Cardiovascular regulatory mechanisms in advanced age", Physiol Rev, 73, pp.413~467 (1993)
81. Taffet GE, "Exercise training improves lusitropy by isoproterenol in papillary muscles from aged rats", J Appl Physiol, 81, pp.1488~1494 (1996)
82. Takagishi Y, "Spatial distribution of dihydropyridine receptors in the plasma membrane of guinea pig cardiac myocytes investigated by correlative confocal microscopy and label-fracture electron microscopy", J Electron Microsc (Tokyo), 46, pp.165~170 (1997)
83. Tate CA, "SERCA2a and mitochondrial cytochrome oxidase expression are increased in hearts of exercise-trained old rats", Am J Physiol, 271, pp.h68~h72 (1996)
84. Schmidt U, "Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca2+- ATPase", Circulation, 101, pp.790~796 (2000)
85. Wahr PA, "Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes", Proc Natl Acad Sci, 96, pp.11982~11985 (1999)
86. Celio MR, "Calcium-binding protein parvalbumin is associated with fast contracting muscle fibres", Nature, 297, pp.504~506 (1982)
87. Hou TT, "Parvalbumin content and Ca2+ and Mg2+ dissociation rates correlated with changes in relaxation rate of frog muscle fibres", J Physiol, 441, pp.285~304 (1991)
88. Rall JA, "le of parvalbumin in skeletal muscle contraction", News in Physiological Science, 11, pp.249~255 (1996)
89. Szatkowski ML, "In vivo acceleration of heart relaxation performance by parvalbumin gene delivery", J Clin Invest, 107, pp.191~198 (2001)
90. Oh JK, "The noninvasive assessment of left ventriclar diastolic function with two-dimensional and Doppler echocardiography", J Am Soc Echocardiogr, 10, pp.246~270 (1997)
91. Nishimura RA, "Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone", J Am Coll Cardiol, 30, pp.8~18 (1997)

관련 논문AI추천